Adalimumab treatment for pyoderma gangrenosum

Arch Dermatol. 2007 Mar;143(3):306-8. doi: 10.1001/archderm.143.3.306.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Middle Aged
  • Pyoderma Gangrenosum / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Adalimumab